Correlation Between Transcode Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Transcode Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Mereo BioPharma.
Diversification Opportunities for Transcode Therapeutics and Mereo BioPharma
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Transcode and Mereo is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Mereo BioPharma. In addition to that, Transcode Therapeutics is 1.69 times more volatile than Mereo BioPharma Group. It trades about -0.43 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.15 per unit of volatility. If you would invest 420.00 in Mereo BioPharma Group on August 27, 2024 and sell it today you would lose (48.00) from holding Mereo BioPharma Group or give up 11.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Transcode Therapeutics vs. Mereo BioPharma Group
Performance |
| Timeline |
| Transcode Therapeutics |
| Mereo BioPharma Group |
Transcode Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Mereo BioPharma
The main advantage of trading using opposite Transcode Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |